US 10391097
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
granted A61KA61K31/519A61P
Quick answer
US patent 10391097 (Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors) held by VTV THERAPEUTICS LLC expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VTV THERAPEUTICS LLC
- Grant date
- Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/519, A61P, A61P1/00, A61P1/02